Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...
Noor is a clinical researcher with advanced training from Harvard who serves as a clinical trial lead for studies at Amicis Clinical Trials. For decades, the pharmaceutical industry’s approach to ...
Millions of people taking semaglutide and similar GLP-1 receptor agonists for diabetes or weight loss may also be experiencing a significant reduction in depression and anxiety symptoms. A Swedish ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
US Health and Human Services Secretary Robert F. Kennedy Jr. announced a plan to reduce “overprescribing” of psychiatric medications and support alternative treatment options and discontinuation of ...
Section 1. Purpose and Policy. Policymakers and the medical field have long struggled to address the burden of suicide and serious mental illness rates in America. Today, over 14 million American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results